Dashboard
Manage Tickers

EYPT


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jefferies-initiates-coverage-on-eyepoint-pharmaceuticals-with-buy-rating-announces-price-target-of-15
Jefferies Initiates Coverage On EyePoint P...
08/28/2024 12:22:13

Jefferies analyst Kambiz Yazdi initiates coverage on EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy rating and announces ...

eyepoint-pharmaceuticals-stock-a-deep-dive-into-analyst-perspectives-4-ratings
EyePoint Pharmaceuticals Stock: A Deep Div...
08/13/2024 13:00:40

jp-morgan-maintains-overweight-on-eyepoint-pharmaceuticals-lowers-price-target-to-29
JP Morgan Maintains Overweight on EyePoint...
08/13/2024 12:33:13

JP Morgan analyst Tessa Romero maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Overweight and lowers the price targe...

eyepoint-pharmaceuticals-cash-and-investments-of-2802m-is-expected-to-provide-cash-runway-into-2026
EyePoint Pharmaceuticals' Cash And Investm...
08/07/2024 11:34:39

eyepoint-pharmaceuticals-q2-2024-gaap-eps-058-misses-053-estimate-sales-9477m-miss-9593m-estimate
EyePoint Pharmaceuticals Q2 2024 GAAP EPS ...
08/07/2024 11:33:31

eyepoint-pharmaceuticals-granted-us-patent-12043664-methods-for-treating-vascular-leak-syndrome-and-cancer
Eyepoint Pharmaceuticals Granted U.S. Pate...
07/23/2024 14:14:43

https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240238387

why-asp-isotopes-shares-are-trading-lower-by-9-here-are-other-stocks-moving-in-fridays-mid-day-session
Why ASP Isotopes Shares Are Trading Lower ...
07/12/2024 17:14:56

bank-of-new-york-mellon-posts-upbeat-earnings-joins-archer-aviation-rivian-automotive-and-other-big-stocks-moving-higher-on-friday
Bank of New York Mellon Posts Upbeat Earni...
07/12/2024 14:27:17

chardan-capital-maintains-buy-on-eyepoint-pharmaceuticals-maintains-28-price-target
Chardan Capital Maintains Buy on EyePoint ...
06/28/2024 12:31:13

Chardan Capital analyst Daniil Gataulin maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy and maintains $28 price ...

hc-wainwright--co-reiterates-buy-on-eyepoint-pharmaceuticals-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on EyeP...
06/27/2024 10:16:18

HC Wainwright & Co. analyst Yi Chen reiterates EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy and maintains $30 price...

eyepoint-pharmaceuticals-to-highlight-duravyutm-clinical-and-regulatory-developments-at-rd-day-2024
EyePoint Pharmaceuticals To Highlight DURA...
06/26/2024 12:06:00

– Phase 3 trial design for the LUGANO and LUCIA pivotal non-inferiority trials of DURAVYU in wet AMD based on positive EOP2 mee...

cantor-fitzgerald-reiterates-overweight-on-eyepoint-pharmaceuticals
Cantor Fitzgerald Reiterates Overweight on...
06/20/2024 17:34:14

Cantor Fitzgerald analyst Jennifer Kim reiterates EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Overweight.

jp-morgan-maintains-overweight-on-eyepoint-pharmaceuticals-lowers-price-target-to-32
JP Morgan Maintains Overweight on EyePoint...
06/04/2024 13:17:52

JP Morgan analyst Tessa Romero maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Overweight and lowers the price targe...

crocs-to-rally-around-19-here-are-10-top-analyst-forecasts-for-monday
Crocs To Rally Around 19%? Here Are 10 Top...
05/13/2024 12:31:26

hc-wainwright--co-maintains-buy-on-eyepoint-pharmaceuticals-lowers-price-target-to-30
HC Wainwright & Co. Maintains Buy on EyePo...
05/13/2024 10:57:47

HC Wainwright & Co. analyst Yi Chen maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy and lowers the price tar...

eyepoint-pharmaceuticals-q1-cash-and-investments-on-march-31-2024-of-299m-is-expected-to-provide-cash-runway-into-2026
EyePoint Pharmaceuticals' Q1 Cash And Inve...
05/08/2024 11:18:37

eyepoint-pharmaceuticals-q1-2024-gaap-eps-055-misses-042-estimate-sales-11684m-beat-9986m-estimate
EyePoint Pharmaceuticals Q1 2024 GAAP EPS ...
05/08/2024 11:17:32

baird-maintains-outperform-on-eyepoint-pharmaceuticals-lowers-price-target-to-38
Baird Maintains Outperform on EyePoint Pha...
05/08/2024 11:02:17

Baird maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Outperform and lowers the price target from $46 to $38.

flywire-reports-q1-loss-joins-zoominfo-inspire-medical-systems-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Flywire Reports Q1 Loss, Joins ZoomInfo, I...
05/08/2024 10:05:47

deep-dive-into-eyepoint-pharmaceuticals-stock-analyst-perspectives-4-ratings
Deep Dive Into EyePoint Pharmaceuticals St...
05/07/2024 17:00:17

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION